Inhibrx Biosciences, Inc. (INBX) NASDAQ
93.63
-5.66(-5.70%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
93.63
-5.66(-5.70%)
Currency In USD
| Market Cap | 1.22B |
| Enterprise Value | 1.21B |
| P/E Ratio | -11.21 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 1,056.66 |
| Price/Book Ratio | -69.37 |
| Enterprise/Revenue | 936.85 |
| Enterprise/EBITDA | -10.4 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -100.14 |
| Operating Margin | -94.65 |
| Return On Assets | -0.71 |
| Return On Equity | -5.64 |
| Revenue | 1.3M |
| Revenue/Share | 0.08 |
| Gross Profit | -1.18M |
| EBITDA | -132.54M |
| Net Income | -140.06M |
| Diluted EPS | -9.04 |
| Total Cash | 161.66M |
| Total Cash/Share | 10.37 |
| Total Debt | 5.9M |
| Total Debt/Equity | -0.28 |
| Current Ratio | 6.46 |
| Book Value Per Share | -1.35 |
| 52-Week Change | 622.45 |
| 52-Week High | 155.29 |
| 52-Week Low | 12.8 |
| Moving Average 50 Days | 97.9 |
| Moving Average 200 Days | 71.09 |
| Average Volume | 407,068 |
| Shares Outstanding | 14.67M |
| % Held by Institutions | 82.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |